Sleeping Pills: Market Research Report

August 2010 | 354 pages | ID: SF0672EC6EAEN
Global Industry Analysts, Inc

Abstracts

This report analyzes the Global market for Sleeping Pills in US$ Million.

Annual estimates and forecasts are provided for the period of 2007 through 2015.

Also, a six-year historic analysis is provided for this market.

The report profiles 34 companies including many key and niche players such as Actelion Pharmaceuticals Ltd., Abbott India Limited, Apotex Inc., Aurobindo Pharma Limited, Caraco Pharmaceutical Laboratories, Ltd., Dr. Reddy’s Laboratories Limited, H. Lundbeck A/S, King Pharmaceuticals Inc., Neurocrine Biosciences, Ranbaxy Laboratories Limited, Roxane Laboratories, Inc., Sepracor Inc ., Sanofi-aventis, Somaxon Pharmaceuticals Inc., Synthon BV, Takeda Pharmaceutical Company Limited, and Transcept Pharmaceuticals, Inc.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definition and Scope of Study

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Safety Concerns and Generics Characterize the Market
“Perfect” Treatment Option Continues to Evade Insomnia Therapeutics Arena
A Market Characterized by Weak Pipeline
Market Outlook
Sleep Disorders – Not Confined to Elderly Alone
US Leads the Global Market for Sleeping Pills

Table 1. US Prevalence of Chronic Insomnia by Type: 2008 (includes corresponding Graph/Chart)

Studies Cast Doubt On the Efficacy of Sleeping Pills

2.SLEEPING PILLS MARKET SEGMENTATION

Market Categorization

Table 2. Select Benzodiazepines and Non-Benzodiazepines Worldwide

Benzodiazepines Loose Sheen Due to Associated Side Effects
‘Z’ Drugs Outshine Benzodiazepines with Lesser Adverse Effects

Table 3. Sales of Select Leading Sleeping Pills Worldwide

Melatonin Receptor Agonist Hypnotic
Rozerem – The Only Drug without the Risk of Dependency

3.MAJOR SLEEPING PILLS WORLDWIDE

Zolpidem (Sanofi-Aventis/Various)
Ambien CR (Sanofi-Aventis)
Lunesta (Sepracor)
Intermezzo (Transcept)
Sonata (King Pharmaceuticals)
Imovane (Sanofi-Aventis)

4.SLEEP DISORDER PIPELINE ANALYSIS

5.PRODUCT OVERVIEW

Insomnia – A Review
Impact on Day-to-day Life
Insomnia: An Under-Diagnosed Disease
Middle-Of-The-Night Insomnia
What are Sleeping Pills?
When it Should be Taken?
Side Effects – A Key Concern
Natural Treatment of Insomnia
Eye Cells – A New Potential Target for Sleeping Pills

6.REGIONAL MARKET PERSPECTIVE

6A.THE UNITED STATES

Economic Woes Drive Usage of Sleeping Pills

Table 4. Sleeping Pills Prescription Volume in the US: 2006-2008 (includes corresponding Graph/Chart)

Table 5. Sleeping Pills Prescription Volume in the US by Drug: 2006-2008 (In Million) (includes corresponding Graph/Chart)

Dangerous Signs for Americans
OTC Sleeping Aids Market Review

Table 6. Leading OTC Sleeping Aid Tablets in the US (2008): Percentage Breakdown of Value Sales for Simply Sleep, Unisom SleepGels, Unisom SleepTabs, Sleep MD, Sominex, Midnite, Breathe Right, Sleepinal, Private Label Brands and Others (includes corresponding Graph/Chart)

Table 7. Leading OTC Sleeping Aid Tablets in the US (2008): Percentage Breakdown of Volume Sales for Simply Sleep, Unisom SleepGels, Sominex, Unisom SleepTabs, Sleep MD, Midnite, Sleepinal, Breathe Right, Private Labels and Others (includes corresponding Graph/Chart)

Table 8. Leading OTC Sleeping Aid Liquid Drugs in the US Drug Stores (2007): Percentage Breakdown of Value Sales for Breathe Right, Snorestop, Bach Rescue Sleep, Nutramist Sleep Now, Nutranetics Liquid Sleep and Others (includes corresponding Graph/Chart)

Table 9. Leading OTC Sleeping Pills in US Drug Stores (2007): Percentage Breakdown of Value Sales for Simply Sleep, Unisom Sleepgels, Sleep MD, Unisom, Sominex and Others (includes corresponding Graph/Chart)

Table 10. Leading OTC Sleeping Pills in US Drug Stores (2007): Percentage Breakdown of Volume Sales for Simply Sleep, Unisom Sleepgels, Sominex, Unisom, Sleep MD and Others (includes corresponding Graph/Chart)

6B.EUROPE

Europe: A Major Market for Sleeping Pills

Table 11. European Prevalence of Chronic Insomnia by Type: 2008 (includes corresponding Graph/Chart)

Table 12. Sleeping Disorders in Europe (2008): Prevalence Rate by Age Group for Select European Countries – France, Germany, Italy, UK (includes corresponding Graph/Chart)

Table 13. Sleeping Disorders in Europe (2008): Prevalence Rate by Gender for Select European Countries – France, Germany, Italy, UK (includes corresponding Graph/Chart)

6C.JAPAN

Illegal Sales of Sleeping Pills Rampant in Japan

6D.TAIWAN

Sleeping Pills Sales Continue to Soar

7.RECENT INDUSTRY ACTIVITY

Somaxon Pharma Receives US FDA Approval for Silenor
Transcept Pharmaceuticals Merges with Novacea
Sepracor Files Lawsuits Against ANDA Filers for Eszopiclone
Dainippon Sumitomo Takes Over Sepracor
FDA Puts Two Pediatric Studies of Lunesta on Hold
Transcept Pharmaceuticals Signs Deal with Purdue Pharmaceutical Products
Sepracor Receives Approval for Lunesta Oral Tablet
FDA Approves Mylan’s ANDA for Zaleplon Capsules
GlaxoSmithKline Signs Agreement with Actelion
Lundbeck Launches Circadin® in Germany for Insomnia
Lundbeck Launches Circadin in the UK
Transcept Completes Phase III Study of Intermezzo, Files NDA
Evotec Scouts for Partners to Develop EVT 201
Aurobindo Pharma Receives FDA Approval for Zaleplon
Australia’s TGA Orders Boxed Warnings for Stilnox
Sepracor Obtains Positive Opinion for Approval of Lunivia from CHMP
Caraco Obtains FDA Approval for Generic Zolpidem
FDA Approves ANDA of Dr. Reddy's Laboratories for Zolpidem Tartrate
Ranbaxy Obtains FDA Clearance to Market Generic Ambien®
Neurocrine Obtains Second Approvable Letter from FDA for Indiplon Capsules
Roxane Launches Zolpidem Tartrate Tablets

8.FOCUS ON SELECT PLAYERS

Actelion Pharmaceuticals Ltd. (Switzerland)
Abbott India Limited (India)
Apotex Inc. (Canada)
Aurobindo Pharma Limited (India)
Caraco Pharmaceutical Laboratories, Ltd. (US)
Dr. Reddy’s Laboratories Limited (India)
H. Lundbeck A/S (Denmark)
King Pharmaceuticals, Inc. (US)
Neurocrine Biosciences (US)
Ranbaxy Laboratories Limited (India)
Roxane Laboratories, Inc. (US)
Sepracor, Inc. (USA)
Sanofi-aventis (France)
Somaxon Pharmaceuticals, Inc. (US)
Synthon BV (The Netherlands)
Takeda Pharmaceutical Company Limited (Japan)
Transcept Pharmaceuticals, Inc. (US)

9.GLOBAL MARKET PERSPECTIVE

Table 14. World Recent Past, Current and Future Analysis for Sleeping Pills by Geographic Region – US, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 15. World Historic Review for Sleeping Pills by Geographic Region – US, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

Table 16. World 13-Year Perspective for Sleeping Pills by Geographic Region – Percentage Breakdown of Dollar Sales for US, and Rest of World Markets for Years 2003, 2009 and 2015

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 34 (including Divisions/Subsidiaries - 39)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Rest of Europe
Asia-Pacific (Excluding Japan)